InspireMD (NSPR) Announces Positive Long-Term Safety and Efficacy Data from Ongoing CGuard™ EPS Registries at VEITHsymposium
Tweet Send to a Friend
InspireMD, Inc. (NYSE : NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
